Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing
- Written by PR Newswire
![]() |
NORWALK, Conn., May 19, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, today announced that it has led Violet Therapeutics' $4.75 million seed extension financing, with participation from Dementia Discovery Fund, UTEC, Ono Venture Investment, and Mass General Brigham...
Read more: Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing















